Inactive Instrument
Ocata Therapeutics Inc Stock
Stocks
US67457L1008
Biotechnology & Medical Research
|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| Manager | Title | Age | Since |
|---|---|---|---|
John Heffernan
PRN | Corporate Officer/Principal | - | 2015-02-02 |
| Director | Title | Age | Since |
|---|---|---|---|
Toru Yoshimitsu
BRD | Director/Board Member | 63 | - |
Masaaki Hirano
BRD | Director/Board Member | 59 | - |
| Director/Board Member | 53 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.43% | -7.34% | +36.10% | +58.44% | 62.23B | |
| +0.61% | +0.77% | +11.13% | +69.42% | 54.92B | |
| +0.62% | +2.58% | +20.96% | +98.18% | 55.26B | |
| +2.06% | -3.07% | +23.07% | +33.48% | 42.59B | |
| -1.67% | -2.52% | +14.42% | +94.17% | 41.08B | |
| +3.52% | +4.69% | +228.59% | +779.76% | 40.33B | |
| +0.57% | +24.09% | +99.46% | +84.11% | 33.12B | |
| -1.09% | -0.05% | +13.55% | +45.35% | 32.61B | |
| -3.84% | +10.80% | -43.50% | +323.42% | 23.98B | |
| Average | -0.16% | +3.75% | +44.86% | +176.26% | 42.9B | |
| Weighted average by Cap. | -0.05% | +2.11% | +45.33% | +159.63% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
